approval · primary record
CLESROVIMAB-CFOR
FDA · BLA · 2026-10-14
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-10-14 |
| Brand | ENFLONSIA |
| Sponsor | MERCK SHARP DOHME |
| Route | SOLUTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:29.030Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CLESROVIMAB-CFOR:2026-10-14
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.